P2 1L Mono NSCLC CB 201
Research payments
$663,109
Through program year 2024, $663,109 in research payments was reported against P2 1L Mono NSCLC CB 201, across 59 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $9,634 | 2 |
| 2023 | Research | $247,864 | 19 |
| 2022 | Research | $405,611 | 38 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Marianna Koczywas Duarte, CA Named on 3 payments
- Lewis Attas Englewood, NJ Named on 2 payments
- Gregory Durm Indianapolis, IN Named on 2 payments
- Timothy Burns Pittsburgh, PA Named on 2 payments
- Ferdinandos Skoulidis Houston, TX Named on 2 payments
- Jyoti Malhotra New Brunswick, NJ Named on 2 payments
- Julio Peguero Houston, TX Named on 2 payments
- Steven McCune Marietta, GA Named on 2 payments
- Jason MacKlis Park Ridge, IL Named on 2 payments
- Gene Finley Natrona Heights, PA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.